CSIMarket
 


Concert Pharmaceuticals Inc   (CNCE)
Other Ticker:  
 
 

CNCE's Income Taxes Growth by Quarter and Year

Concert Pharmaceuticals Inc 's Income Taxes results by quarter and year




CNCE Income Taxes (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - 0.00 0.17 0.00
III Quarter September 0.00 0.00 0.00 0.00
II Quarter June 0.00 0.00 -0.09 0.00
I Quarter March 0.00 0.00 0.00 0.00
FY   0.00 0.00 0.08 0.00



CNCE Income Taxes third quarter 2022 Y/Y Growth Comment
Concert Pharmaceuticals Inc in the third quarter 2022 recorded Provisions for income taxes of $ 0.00 millions.

According to the results reported in the third quarter 2022, Concert Pharmaceuticals Inc achieved the best Income Taxes growth in Major Pharmaceutical Preparations industry. While Concert Pharmaceuticals Inc ' s Income Taxes no change of % ranks overall at the positon no. in the third quarter 2022.

Explain Operating Income growth


CNCE Income Taxes ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Concert Pharmaceuticals Inc 's third quarter 2022 Income Taxes $ 0.00 millions CNCE's Income Statement
Concert Pharmaceuticals Inc 's third quarter 2021 Income Taxes $ 0.00 millions Quarterly CNCE's Income Statement
New: More CNCE's historic Income Taxes Growth >>


CNCE Income Taxes (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Income Taxes third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income Taxes Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Income Taxes third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income Taxes Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Income Taxes by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Concert Pharmaceuticals Inc 's Q/Q Income Taxes Growth


Income Taxes Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CNCE's III. Quarter Q/Q Income Taxes Comment


Income Taxes Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income Taxes Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Income Taxes Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CNCE's III. Quarter Q/Q Income Taxes Comment


Concert Pharmaceuticals Inc 's 12 Months Income Taxes Growth Year on Year


Income Taxes TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Income Taxes 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Income Taxes Growth (TTM) - - - - -
Year on Year Income Taxes Growth Overall Ranking # # # # #
Seqeuential Income Taxes Change (TTM) - - - - -
Seq. Income Taxes Growth (TTM) Overall Ranking # # # # #




Cumulative Income Taxes growth Comment
In the Sep 30 2022 period, Concert Pharmaceuticals Inc 's cumulative trailing twelve month Income Taxes remained unchanged compare to the same period a year ago.

Concert Pharmaceuticals Inc achieved highest trailing twelve month year on year Income Taxes growth. While overall Income Taxes growth ranking, remained unchanged compare to the previous quarter at no. .

Income Taxes TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Income Taxes TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income Taxes TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income Taxes TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Income Taxes growth Comment
In the Sep 30 2022 period, Concert Pharmaceuticals Inc 's cumulative trailing twelve month Income Taxes remained unchanged compare to the same period a year ago.

Concert Pharmaceuticals Inc achieved highest trailing twelve month year on year Income Taxes growth. While overall Income Taxes growth ranking, remained unchanged compare to the previous quarter at no. .

Income Taxes TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income Taxes TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Income Taxes TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Income Taxes TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Income Taxes Growth
Major Pharmaceutical Preparations Industry Income Taxes Growth Trends and Statistics
Healthcare Sector Income Taxes Growth Statistics
Income Taxes Growth Trends for overall market
CNCE's Income Taxes Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Income Taxes Growth
Lowest Ranking Income Taxes Growth
Income Taxes Growth for CNCE's Competitors
Income Taxes Growth for Concert Pharmaceuticals Inc 's Suppliers
Income Taxes Growth for CNCE's Customers

You may also want to know
CNCE's Annual Growth Rates CNCE's Profitability Ratios CNCE's Asset Turnover Ratio CNCE's Dividend Growth
CNCE's Roe CNCE's Valuation Ratios CNCE's Financial Strength Ratios CNCE's Dividend Payout Ratio
CNCE's Roa CNCE's Inventory Turnover Ratio CNCE's Growth Rates CNCE's Dividend Comparisons



Companies with similar Income Taxes no change for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Income Taxes for the quarter ending Sep 30 2022
Fonar Corporation-0.49%$ -0.494 millions
Bristol myers Squibb Company-0.66%$ -0.661 millions
Collegium Pharmaceutical Inc -1.61%$ -1.615 millions
Ensign Group Inc-1.82%$ -1.817 millions
Amphastar Pharmaceuticals Inc -1.90%$ -1.899 millions
Henry Schein Inc-6.65%$ -6.648 millions
Conformis inc -6.90%$ -6.897 millions
Resmed Inc -7.00%$ -6.996 millions
Cumberland Pharmaceuticals Inc-7.48%$ -7.482 millions
Amgen Inc -8.12%$ -8.118 millions
Cerus Corporation-8.22%$ -8.219 millions
Personalis Inc -8.33%$ -8.333 millions
Repligen Corp-8.69%$ -8.689 millions
Boston Scientific Corporation-10.94%$ -10.938 millions
Reviva Pharmaceuticals Holdings Inc -11.32%$ -11.323 millions
Abbvie inc -11.81%$ -11.811 millions
Amedisys Inc -12.24%$ -12.245 millions
Catalyst Pharmaceuticals Inc -12.93%$ -12.931 millions
Pediatrix Medical Group Inc -13.31%$ -13.309 millions
National Research Corporation-14.09%$ -14.088 millions
Twist Bioscience Corporation-14.12%$ -14.118 millions
Addus Homecare Corporation-14.79%$ -14.788 millions
Universal Health Services Inc -14.98%$ -14.980 millions
U S Physical Therapy Inc-15.73%$ -15.727 millions
Eli Lilly And Company-15.83%$ -15.828 millions
Semler Scientific Inc -16.35%$ -16.350 millions
3m Company-16.36%$ -16.358 millions
Jounce Therapeutics inc -16.67%$ -16.667 millions
Organon and Co -16.67%$ -16.667 millions
Abbott Laboratories-17.81%$ -17.812 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com